Eris Lifesciences Ltd
NSE:ERIS

Watchlist Manager
Eris Lifesciences Ltd Logo
Eris Lifesciences Ltd
NSE:ERIS
Watchlist
Price: 1 374.2 INR 0.53% Market Closed
Market Cap: 187B INR
Have any thoughts about
Eris Lifesciences Ltd?
Write Note

Eris Lifesciences Ltd
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Eris Lifesciences Ltd
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Eris Lifesciences Ltd
NSE:ERIS
Depreciation & Amortization
-â‚ą2.2B
CAGR 3-Years
-67%
CAGR 5-Years
-40%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Depreciation & Amortization
-â‚ą15B
CAGR 3-Years
-7%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Depreciation & Amortization
-â‚ą10.4B
CAGR 3-Years
0%
CAGR 5-Years
5%
CAGR 10-Years
-9%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Depreciation & Amortization
-â‚ą25.5B
CAGR 3-Years
-6%
CAGR 5-Years
-7%
CAGR 10-Years
-14%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Depreciation & Amortization
-â‚ą8.1B
CAGR 3-Years
-7%
CAGR 5-Years
-5%
CAGR 10-Years
-21%
M
Mankind Pharma Ltd
NSE:MANKIND
Depreciation & Amortization
-â‚ą4B
CAGR 3-Years
-50%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Eris Lifesciences Ltd
Glance View

Market Cap
186.9B INR
Industry
Pharmaceuticals

Eris Lifesciences Ltd. engages in the provision of pharmaceutical products. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2017-06-29. The Company’s manufacturing plant is located in Guwahati, Assam. Its therapeutic areas include oral diabetes care, cardiac care, pain/analgesics, gynecology, gastrointestinal, central nervous system (CNS), and vitamins, minerals and nutrients (VMN). The firm's brands include Glimisave, Eritel, Renerve, Tendia, Olmin, Rabonik, Tayo, Cyblex, Lnbloc, Remylin, Zomelis, Crevast, Atorsave, Ginkocer and Metital. The Company’s wholly owned subsidiaries include Kinedex Healthcare Private Limited, Aprica Healthcare Limited and Eris Healthcare Private Limited.

ERIS Intrinsic Value
1 082.77 INR
Overvaluation 21%
Intrinsic Value
Price

See Also

What is Eris Lifesciences Ltd's Depreciation & Amortization?
Depreciation & Amortization
-2.2B INR

Based on the financial report for Jun 30, 2024, Eris Lifesciences Ltd's Depreciation & Amortization amounts to -2.2B INR.

What is Eris Lifesciences Ltd's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
-40%

Over the last year, the Depreciation & Amortization growth was -62%. The average annual Depreciation & Amortization growth rates for Eris Lifesciences Ltd have been -67% over the past three years , -40% over the past five years .

Back to Top